A detailed history of Peregrine Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 405,261 shares of EW stock, worth $30.5 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
405,261
Previous 409,149 0.95%
Holding current value
$30.5 Million
Previous $37.8 Million 29.24%
% of portfolio
0.84%
Previous 1.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$59.7 - $93.78 $232,113 - $364,616
-3,888 Reduced 0.95%
405,261 $26.7 Million
Q2 2024

Jul 29, 2024

BUY
$84.3 - $94.31 $680,806 - $761,647
8,076 Added 2.01%
409,149 $37.8 Million
Q1 2024

Apr 26, 2024

SELL
$72.54 - $95.56 $490,080 - $645,603
-6,756 Reduced 1.66%
401,073 $38.3 Million
Q4 2023

Jan 26, 2024

SELL
$61.71 - $77.76 $975,881 - $1.23 Million
-15,814 Reduced 3.73%
407,829 $31.1 Million
Q3 2023

Oct 19, 2023

BUY
$69.28 - $93.38 $7,759 - $10,458
112 Added 0.03%
423,643 $29.3 Million
Q2 2023

Jul 26, 2023

SELL
$81.41 - $94.33 $380,591 - $440,992
-4,675 Reduced 1.09%
423,531 $40 Million
Q1 2023

Apr 26, 2023

BUY
$74.26 - $84.51 $380,359 - $432,860
5,122 Added 1.21%
428,206 $35.4 Million
Q4 2022

Jan 10, 2023

BUY
$68.3 - $87.44 $442,925 - $567,048
6,485 Added 1.56%
423,084 $31.6 Million
Q3 2022

Oct 26, 2022

SELL
$82.37 - $107.29 $476,839 - $621,101
-5,789 Reduced 1.37%
416,599 $34.4 Million
Q2 2022

Jul 20, 2022

SELL
$86.5 - $128.27 $2.2 Million - $3.27 Million
-25,467 Reduced 5.69%
422,388 $40.2 Million
Q1 2022

Apr 27, 2022

SELL
$101.96 - $128.34 $3.87 Million - $4.87 Million
-37,938 Reduced 7.81%
447,855 $52.7 Million
Q4 2021

Jan 31, 2022

BUY
$106.37 - $130.68 $4.43 Million - $5.44 Million
41,643 Added 9.38%
485,793 $62.9 Million
Q3 2021

Nov 02, 2021

SELL
$102.91 - $122.75 $352,775 - $420,787
-3,428 Reduced 0.77%
444,150 $50.3 Million
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $1.72 Million - $2.15 Million
20,564 Added 4.82%
447,578 $46.4 Million
Q1 2021

May 11, 2021

BUY
$78.68 - $90.67 $2.35 Million - $2.71 Million
29,871 Added 7.52%
427,014 $35.7 Million
Q4 2020

Jan 19, 2021

BUY
$71.69 - $91.23 $3.63 Million - $4.62 Million
50,687 Added 14.63%
397,143 $36.2 Million
Q3 2020

Oct 20, 2020

BUY
$67.19 - $87.44 $4.76 Million - $6.19 Million
70,823 Added 25.69%
346,456 $27.7 Million
Q2 2020

Jul 30, 2020

BUY
$57.54 - $76.95 $10.7 Million - $14.4 Million
186,671 Added 209.83%
275,633 $19 Million
Q1 2020

Apr 17, 2020

BUY
$52.41 - $81.0 $36,529 - $56,457
697 Added 0.79%
88,962 $5.59 Million
Q4 2019

Jan 16, 2020

BUY
$71.7 - $82.09 $23,732 - $27,171
331 Added 0.38%
88,265 $6.86 Million
Q3 2019

Oct 16, 2019

SELL
$61.55 - $75.43 $1.04 Million - $1.28 Million
-16,924 Reduced 16.14%
87,934 $6.45 Million
Q1 2019

Apr 12, 2019

BUY
$47.89 - $64.05 $59,383 - $79,422
1,240 Added 1.2%
104,858 $0
Q4 2018

Jan 17, 2019

BUY
$46.41 - $56.94 $119,737 - $146,905
2,580 Added 2.55%
103,618 $5.29 Million
Q2 2018

Jul 12, 2018

BUY
$42.45 - $51.3 $14,008 - $16,929
330 Added 0.33%
101,038 $0
Q1 2018

Apr 16, 2018

SELL
$37.19 - $47.45 $14,057 - $17,936
-378 Reduced 0.37%
100,708 $0
Q3 2017

Oct 25, 2017

BUY
$36.29 - $38.83 $3.67 Million - $3.93 Million
101,086
101,086 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.